2P2Idb v2: update of a structural database dedicated to orthosteric modulation of protein–protein interactions
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
2P2Idb is a hand-curated structural database dedicated to protein-protein interactions with known small molecule orthosteric modulators. It compiles the structural information related to orthosteric inhibitors and their target [i.e. related 3D structures available in the RCSB Protein Data Bank (PDB)] and provides links to other useful databases. 2P2Idb includes all interactions for which both the protein-protein and protein-inhibitor complexes have been structurally characterized. Since its first release in 2010, the database has grown constantly and the current version contains 27 protein-protein complexes and 274 protein-inhibitor complexes corresponding to 242 unique small molecule inhibitors which represent almost a 5-fold increase compared to the previous version. A number of new data have been added, including new protein-protein complexes, binding affinities, molecular descriptors, precalculated interface parameters and links to other webservers. A new query tool has been implemented to search for inhibitors within the database using standard molecular descriptors. A novel version of the 2P2I-inspector tool has been implemented to calculate a series of physical and chemical parameters of the protein interfaces. Several geometrical parameters including planarity, eccentricity and circularity have been added as well as customizable distance cutoffs. This tool has also been extended to protein-ligand interfaces. The 2P2I database thus represents a wealth of structural source of information for scientists interested in the properties of protein-protein interactions and the design of protein-protein interaction modulators. Database URL: http://2p2idb.cnrs-mrs.fr.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent efforts in developing clinical PPI inhibitors have focused on targeting “hotspots” that typically span 250–900 Å2 of the PPI interface [25].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Protein Structure Modeling with MODELLER
Eswar, N., Eramian, D., Webb, B., Shen, M.-Y., & Sali, A. (2008) · Methods in Molecular Biology · doi:10.1007/978-1-60327-058-8_8 · Cited by 1,773
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065
SURFNET: A program for visualizing molecular surfaces, cavities, and intermolecular interactions
Laskowski, R. A. (1995) · Journal of Molecular Graphics · doi:10.1016/0263-7855(95)00073-9 · Cited by 1,002
PDB-wide collection of binding data: current status of the PDBbind database
Liu, Z., Li, Y., Han, L., Li, J., Liu, J., Zhao, Z., Nie, W., Liu, Y., & Wang, R. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu626 · Cited by 644
Protein Structure Modeling with MODELLER
Webb, B., & Sali, A. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-4939-0366-5_1 · Cited by 549
The RCSB Protein Data Bank: new resources for research and education
Rose, P. W., Bi, C., Bluhm, W. F., Christie, C. H., Dimitropoulos, D., Dutta, S., Green, R. K., Goodsell, D. S., Prlić, A., Quesada, M., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1200 · Cited by 527
Binding MOAD (Mother Of All Databases)
Hu, L., Benson, M. L., Smith, R. D., Lerner, M. G., & Carlson, H. A. (2005) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20512 · Cited by 328
Protein–protein interaction inhibitors get into the groove
Mullard, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3680 · Cited by 243
Research works printed but not linked: 1
- Sperandio, 2015, Chemical libraries dedicated to protein-protein interactions, Med. Sci, 31, 312
Cited by
Lagorce, D., Douguet, D., Miteva, M. A., & Villoutreix, B. O. (2017) · Scientific Reports · doi:10.1038/srep46277 · Cited by 266
Vangone, A., Schaarschmidt, J., Koukos, P., Geng, C., Citro, N., Trellet, M. E., Xue, L. C., & Bonvin, A. M. J. J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty816 · Cited by 258
Khodayari, A., & Maranas, C. D. (2016) · Nature Communications · doi:10.1038/ncomms13806 · Cited by 230
“78% 85% 80 63 50% 70 98 k-ecoli457 Core model Core model Metabolite concentrations ΔppsA (42) ΔpykF (49) ΔfbaB (40) ΔpfkB (54) ΔtktB (51) ΔgpmB (52) ΔpykA (50) ΔtaIA (51) ΔtktA (52) ΔpgI (46) ΔtaIB (25) ΔgpmA (38) Δrpe (52) ΔpfkA (35) Δgnd (47) ΔrpiA (53) Δpgi (35) Δzwf (36) ΔrpiB (48) 0 5 10 Average relative error wt…”
Why Some Targets Benefit from beyond Rule of Five Drugs
Egbert, M. E., Whitty, A., Keserű, G. M., & Vajda, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01732 · Cited by 134
Ni, D., Lu, S., & Zhang, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21585 · Cited by 116
“The standard size of a PPI interface is estimated to be 1200 to 2000 Å2,32 but the actual cases may vary from 1000 to 6000 Å2.”
BackgroundInfluentialEvolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
Macalino, S. J. Y., Basith, S., Clavio, N. A. B., Chang, H., Kang, S., & Choi, S. (2018) · Molecules · doi:10.3390/molecules23081963 · Cited by 125
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
Computer-Aided Drug Discovery for Undruggable Targets
Sun, Q., Wang, H., Xie, J., Wang, L., Mu, J., Li, J., Ren, Y., & Lai, L. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00969 · Cited by 82
HawkRank: a new scoring function for protein–protein docking based on weighted energy terms
Feng, T., Chen, F., Kang, Y., Sun, H., Liu, H., Li, D., Zhu, F., & Hou, T. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0254-7 · Cited by 79
Current Challenges and Opportunities in Designing Protein–Protein Interaction Targeted Drugs
Shin, W., Kumazawa, K., Imai, K., Hirokawa, T., & Kihara, D. (2020) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s235542 · Cited by 100
Structure-based assessment and druggability classification of protein–protein interaction sites
Alzyoud, L., Bryce, R. A., Sorkhy, M. A., Atatreh, N., & Ghattas, M. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-12105-8 · Cited by 62
Survey of Similarity-Based Prediction of Drug-Protein Interactions
Wang, C., & Kurgan, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190808154841 · Cited by 52
The iPPI-DB initiative: a community-centered database of protein–protein interaction modulators
Torchet, R., Druart, K., Ruano, L. C., Moine-Franel, A., Borges, H., Doppelt‐Azeroual, O., Brancotte, B., Mareuil, F., Nilges, M., Ménager, H., et al. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa1091 · Cited by 52
Fr-PPIChem: An Academic Compound Library Dedicated to Protein–Protein Interactions
Bosc, N., Müller, C., Hoffer, L., Lagorce, D., Bourg, S., Derviaux, C., Gourdel‐Martin, M., Rain, J., Miller, T. W., Villoutreix, B. O., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00179 · Cited by 47
Self-citationGoncearenco, A., Li, M., Simonetti, F. L., Shoemaker, B. A., & Panchenko, A. R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7201-2_15 · Cited by 44
Protein–Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery
Milhas, S., Raux, B., Betzi, S., Derviaux, C., Roche, P., Restouin, A., Basse, M.-J., Rebuffet, E., Lugari, A., Badol, M., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00286 · Cited by 44
Self-citationGupta, P., & Mohanty, D. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab111 · Cited by 38
Kosugi, T., & Ohue, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010925 · Cited by 40
Camps-Fajol, C., Cavero, D., Minguillón, J., & Surrallés, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107544 · Cited by 36
Structural landscapes of PPI interfaces
Rodrigues, C. H. M., Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac165 · Cited by 37
Mizukoshi, Y., Takeuchi, K., Tokunaga, Y., Matsuo, H., Imai, M., Fujisaki, M., Kamoshida, H., Takizawa, T., Hanzawa, H., & Shimada, I. (2020) · Science Advances · doi:10.1126/sciadv.abd0480 · Cited by 32
pdCSM-PPI: Using Graph-Based Signatures to Identify Protein–Protein Interaction Inhibitors
Rodrigues, C. H. M., Pires, D. E. V., & Ascher, D. B. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01135 · Cited by 37
Current Trends in Macrocyclic Drug Discovery and beyond -Ro5
Alihodžić, S., Bukvić, M., Elenkov, I., Hutinec, A., Koštrun, S., Pešić, D., Saxty, G., Tomašković, L., & Žiher, D. (2018) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2018.01.002 · Cited by 36
Trisciuzzi, D., Nicolotti, O., Miteva, M. A., & Villoutreix, B. O. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.013 · Cited by 28
Zhang, Z., Zhao, L., Wang, J., & Wang, C. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3384238 · Cited by 31
Ikeda, K., Maezawa, Y., Yonezawa, T., Shimizu, Y., Tashiro, T., Kanai, S., Sugaya, N., Masuda, Y., Inoue, N., Niimi, T., et al. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1090643 · Cited by 25
A Multimodal Deep Learning Framework for Predicting PPI-Modulator Interactions
Sun, H., Wang, J., Wu, H., Lin, S. L., Chen, J., Wei, J., Lv, S., Xiong, Y., & Wei, D.-Q. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01527 · Cited by 25
Development of Protein–Protein Interaction Inhibitors for the Treatment of Infectious Diseases
Voter, A. F., & Keck, J. L. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.07.005 · Cited by 24
Houot, L., Navarro, R., Nouailler, M., Duché, D., Guerlesquin, F., & Lloubès, R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.786061 · Cited by 22
Decoding Protein-protein Interactions: An Overview
Slater, O., Miller, B., & Kontoyianni, M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200226105312 · Cited by 23
Silva, F. D., Bret, G., Teixeira, L. D., González, C. F., & Rognan, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01184 · Cited by 21
Skolnick, J., & Zhou, H. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c04525 · Cited by 23
Using a stacked ensemble learning framework to predict modulators of protein–protein interactions
Gao, M., Zhao, L., Zhang, Z., Wang, J., & Wang, C. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107032 · Cited by 22
Mouhsine, H., Guillemain, H., Moreau, G., Fourati, N., Zerrouki, C., Baron, B., Desallais, L., Gizzi, P., Nasr, N. B., Perrier, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03427-z · Cited by 20
Biophysical Techniques for Target Validation and Drug Discovery in Transcription-Targeted Therapy
Moustaqil, M. D., Gambin, Y., & Sierecki, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072301 · Cited by 21
Trisciuzzi, D., Villoutreix, B. O., Siragusa, L., Baroni, M., Cruciani, G., & Nicolotti, O. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2218641 · Cited by 22
Mapping of Protein-Protein Interactions: Web-Based Resources for Revealing Interactomes
Gemović, B., Šumonja, N., Davidović, R., Perović, V., & Veljković, N. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180214113704 · Cited by 18
Lagarde, N., Carbone, A., & Sacquin‐Mora, S. (2018) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25506 · Cited by 16
The Discovery of Cryptic Pockets Increases the Druggability of “Undruggable” Proteins
Mou, M., Yang, W., Huang, G., Yang, X., Zhang, X. L., Kandegama, W., Ashby, C. R., Hao, G., & Gao, Y. (2025) · Medicinal Research Reviews · doi:10.1002/med.70001 · Cited by 15
Exploring the chemical space of protein–protein interaction inhibitors through machine learning
Choi, J., Yun, J. S., Song, H., Kim, N. H., Kim, H. S., & Yook, J. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-92825-5 · Cited by 14
Quantitative Estimate of Protein-Protein Interaction Targeting Drug-likeness
Kosugi, T., & Ohue, M. (2021) · IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB) · doi:10.1109/cibcb49929.2021.9562931 · Cited by 12
DiPPI: A Curated Data Set for Drug-like Molecules in Protein–Protein Interfaces
Cankara, F., Senyuz, S., Sayin, A. Z., Gürsoy, A., & Keskin, Ö. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01905 · Cited by 11
The Future of Computational Chemogenomics
Jacoby, E., & Brown, J. B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8639-2_15 · Cited by 10
Facilities that make the PDB data collection more powerful
Lange, J., Baakman, C. A. B., Pistorius, A. M. A., Krieger, E., Hooft, R. W. W., Joosten, R. P., & Vriend, G. (2019) · Protein Science · doi:10.1002/pro.3788 · Cited by 9
Jain, P., Shah, K., & Rishi, V. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.09.007 · Cited by 9
Shin, W., Kumazawa, K., Imai, K., Hirokawa, T., & Kihara, D. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1110567 · Cited by 8
Multi-level bioinformatics resources support drug target discovery of protein–protein interactions
Liu, J., Zhang, X., Huang, Y., Hao, G., & Yang, G. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103979 · Cited by 8
Zhang, Z., Zhao, L., Gao, M., Chen, Y., Wang, J., & Wang, C. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108287 · Cited by 7
Ohue, M., Kojima, Y., & Kosugi, T. (2023) · Molecules · doi:10.3390/molecules28155652 · Cited by 7
Defining Pharmacological Targets by Analysis of Virus–Host Protein Interactions
Llano, M., & Peña-Hernández, M. A. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.11.001 · Cited by 7
Multimodal Contrastive Learning for Protein–Protein Interaction Inhibitor Prediction
Zhang, Z., Wang, Z., Zhao, L., Wang, J., & Wang, C. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822227 · Cited by 5
Alam, A., Fernández-Cabezudo, M. J., Hamoudi, R., & al-Ramadi, B. K. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00698-z · Cited by 5
Bioinformatics and Plant Stress Management
Shafi, A., & Zahoor, I. (2019) · Springer eBooks · doi:10.1007/978-3-030-19318-8_3 · Cited by 6
Lee, J., Lee, D., & Lee, K. H. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3396-y · Cited by 5
Mohsin, I., Zhang, L.-Q., Li, D., & Papageorgiou, A. C. (2021) · Protein and Peptide Letters · doi:10.2174/0929866528666210316104919 · Cited by 5
Fragment-Based Drug Discovery for Developing Inhibitors of Protein-Protein Interactions
Xiong, B., Wang, Q., & Shen, J. (2018) · Springer eBooks · doi:10.1007/978-981-13-0773-7_6 · Cited by 5
Strategies for in Silico Drug Discovery to Modulate Macromolecular Interactions Altered by Mutations
Poudel, P., Miteva, M. A., & Alexov, E. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26339 · Cited by 3
Databases for Protein-Protein Interaction
Kangueane, P., & Nilofer, C. (2018) · Springer eBooks · doi:10.1007/978-981-10-7347-2_9 · Cited by 3
Structural Chemogenomics Databases to Navigate Protein–Ligand Interaction Space
Kanev, G. K., Kooistra, A. J., de Esch, I. J. P., & de Graaf, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12298-x · Cited by 3
Gheyouche, E., Bagueneau, M., Loirand, G., Offmann, B., & Télétchéa, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.643728 · Cited by 5
Target Mapping in Cancer: Ligandable Protein Pockets on 3D OncoPPI Networks
Trisciuzzi, D., Nicolotti, O., Cruciani, G., Menna, G., & Siragusa, L. (2025) · Pharmaceuticals · doi:10.3390/ph18070958 · Cited by 3
The nucleoside adenosine inhibits intracellular microvascular α2C-adrenoceptor surface trafficking
Shahwar, D. E., Saeed, M., Hazrat, H., Javaid, S., Mohsin, S., Ul‐Haq, Z., & Chotani, M. A. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133637 · Cited by 2
PDID: Database of Experimental and Putative Drug Targets in Human Proteome
Wang, C., Bryliński, M., & Kurgan, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00028-6 · Cited by 2
Bost, H., Derviaux, C., & Longhi, S. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111382 · Cited by 1
A Structural View on Druggability
Egner, U., & Hillig, R. C. (2020) · Wiley eBooks · doi:10.1002/9781118681121.ch2 · Cited by 1
High Throughput Screening Methods for PPI Inhibitor Discovery
Doyle, S. P., Mo, X., Qian, K., Cicka, D., Niu, Q., & Fu, H. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00049 · Cited by 1
Indumathi, D., Ramasamy, S., & Sundaram, P. S. (2021) · International Journal of Life Science and Pharma Research · doi:10.22376/ijpbs/lpr.2021.11.5.l145-150 · Cited by 1
Visualising instance selection for improved explainability using feature extraction
Yeo, G. F. A., Hudson, I., Akman, D., & Chan, J. (2023) · MODSIM · doi:10.36334/modsim.2023.yeo34 · Cited by 1
Predicting small-molecule inhibition of protein complexesPreprint
Yaseen, A., Roy, S., Akhter, N., Ben‐Hur, A., & Minhas, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.23.609286 · Cited by 1
Structural Investigation of Binding Events in Proteins
Clark, J. J. (2018) · Deep Blue (University of Michigan)
Nakadai, M., & Tomida, S. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00607
Sonawane, K. D., & Priya, V. G. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821748-1.00010-5
Quantitative Estimate of Protein-Protein Interaction Targeting Drug-likenessPreprint
Kosugi, T., & Ohue, M. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14489769.v1
Quantitative Estimate of Protein-Protein Interaction Targeting Drug-likenessPreprint
Kosugi, T., & Ohue, M. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14489769
Quantitative estimate of protein-protein interaction targeting drug-likenessPreprint
Kosugi, T., & Ohue, M. (2021) · doi:10.33774/chemrxiv-2021-psqq4-v2
Jahnke, W. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738775439.793580691
Lee, J., Lee, D., & Lee, K. H. (2020) · Figshare · doi:10.6084/m9.figshare.13147253
Imran, M. (2025) · UTUPub (University of Turku)
Développement d'outils pour l'étude des interactions protéine-protéine
Milhas, S. (2016) · theses.fr (ABES) · doi:10.70675/7dcf6f45z231cz483fzb8f5z5cd27c8b0499
Cartographie des interfaces protéine-protéine et recherche de cavités droguables
Silva, F. D. (2016) · theses.fr (ABES) · doi:10.70675/5ed407d7z4b6cz4e08z94f5ze7c2cc4fd624
A yeast-based assay to screen protein-protein interaction modulators
Sudevan, A. (2021) · theses.fr (ABES) · doi:10.70675/9ab04dcaz498fz43ebz8762z012f3f86154c
Développement d’inhibiteurs d’interaction protéine-protéine sélectifs des bromodomaines
Carrasco, K. (2022) · theses.fr (ABES) · doi:10.70675/c6287e64z4b25z4bf4z848bz0244c2289110
Moine-Franel, A. (2023) · theses.fr (ABES) · doi:10.70675/4450e2b8z4b01z4798zbea5z3615171c406a
Pep2Mol: 3D Molecule Generation Targeting Protein-Protein Interfaces with Diffusion ModelsPreprint
Yue, R., Yang, Z., Seabra, G. D. M., Li, C., & Li, Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.28.734975
Jana, T., Karmakar, J., Banerjee, R., & Saha, S. (2026) · Research Square · doi:10.21203/rs.3.rs-10659504/v1
Hudson, I. L., Yeo, A., Hudson, S. A., & Akman, D. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5408-8_2
Hudson, I. L., & Hudson, S. A. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5408-8_1
Computational Peptide Design Methods for Drug Discovery Targeting Protein-Protein Interactions
Kosugi, T. (2024) · Institutional Repositories DataBase (IRDB)
BindingDB Entry 50007004: Why Some Targets Benefit from beyond Rule of Five Drugs.
BindingDB (2021) · UC San Diego · doi:10.7270/q2zg6whw
Lee, J., 조창윤, & Kim, S. (2026) · arXiv (Cornell University) · doi:10.48550/arxiv.2610.41322
Metadata
- Authors
- Basse, M.-J., Betzi, S., Morelli, X., & Roche, P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Roche, Philippe
- Venue
- Database
- Publisher
- Oxford University Press (OUP)
- Published
- 2016
- Volume
- 2016
- Pages
- baw007
- ISSN
- 1758-0463 (ISSN-L)
- PMC
- PMC4792518
- OpenAlex
- W2338762894
- Cited by
- 83
- References
- 35
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 5 · 2021: 13 · 2020: 14 · 2019: 7 · 2018: 11 · 2017: 9 · 2016: 3
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Database (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-15-CE18-0023, CE18‐0023‐01)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- protein-protein interaction, small molecule inhibitors, protein-inhibitor complex, structural database, protein-ligand interface, binding affinity, inhibitor design
- MeSH terms
- Algorithms, Ligands, Proteins, Software, User-Computer Interface, Computational Biology, Internet, Protein Interaction Mapping, Databases, Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.